LOGO-01.png
Burning Rock Announces Plan to Pursue An Alternative Listing
21 juin 2022 01h59 HE | Burning Rock Biotech Limited
GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Reports First Quarter 2022 Financial Results
31 mai 2022 02h32 HE | Burning Rock Biotech Limited
GUANGZHOU, China, May 31, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022
16 mai 2022 04h00 HE | Burning Rock Biotech Limited
GUANGZHOU, China, May 16, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Reports Fourth Quarter and Full Year 2021 Financial Results
21 mars 2022 20h30 HE | Burning Rock Biotech Limited
GUANGZHOU, China, March 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Secures Second NGS Kit Approval from the NMPA
15 mars 2022 09h38 HE | Burning Rock Biotech Limited
GUANGZHOU, China, March 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that the National Medical Products Administration...
LOGO-01.png
Burning Rock to Release MRD Clinical Data on NSCLC and CRC at the Upcoming American Association for Cancer Research Annual Meeting
15 mars 2022 07h29 HE | Burning Rock Biotech Limited
GUANGZHOU, China, March 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it will present MRD (molecular residual disease)...
LOGO-01.png
Burning Rock Schedules Fourth Quarter and Full Year 2021 Earnings Release on March 22, 2022
21 févr. 2022 23h30 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Reaffirms 2021 Revenue Guidance of RMB500 Million
28 déc. 2021 20h05 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that, based on the latest operating trends, the...
LOGO-01.png
Burning Rock Announces Results of 2021 Annual General Meeting
27 déc. 2021 22h00 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Merck KGaA, Darmstadt, Germany and Burning Rock Collaborate on Liquid-biopsy Based CDx Development Using Burning Rock’s OncoCompass Target™
17 nov. 2021 20h15 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a strategic partnership with Merck KGaA, Darmstadt,...